Work

Peripheral T-Cell Reprogramming Characterized by Actin Remodeling and Suppressive Communication in Pembrolizumab-Resistant Lung Adenocarcinoma

Year: 2026
Type: article
Study design: Observational Study
Abstract: Resistance to PD-1 blockade remains a major challenge in lung adenocarcinoma, and the systemic immune mechanisms underlying therapeutic failure are not fully understood. Peripheral blood provides a minimally invasive window to monitor immune remodeling; however, single-cell-level characterization of T-cell alterations associated with pembrolizumab resistance is still limited. Peripheral blood samples from lung adenocarcinoma patients treated with pembrolizumab were collected and stratified into response (CR/PR, n = 3) and nonresponse (SD/PD, n = 4) groups according to RECIST 1.1. Single-cell RNA sequencing was performed to profile immune cell composition and transcriptional states. hdWGCNA was applied to identify response-associated co-expression modules, CellChat was used to intercellular communication, and Monocle2 was employed to explore inferred T-cell state relationships. A total of 91,576 high-quality cells were analyzed. In pooled summaries, patients in the nonresponse group showed a higher relative proportion of CD4+ Treg cells and a lower relative proportion of CD8+ naïve T cells. Network analysis identified 23 module-related DEGs enriched in cytoskeleton- and adhesion-related functional categories. Cell–cell communication analysis predicted increased communication potential, including TGF-β and MIF pathways, and increased adhesion-type interactions such as ADGRE5–CD55 and ITGB2–ICAM1. Pseudotime analysis showed variation in cytoskeleton-associated gene expression (ACTB, ACTG1, PFN1, and S100A family genes) along the inferred trajectory, indicating variation in cytoskeleton-related transcriptional states. These findings associate pembrolizumab nonresponse with altered peripheral T-cell composition, cytoskeleton- and adhesion-related transcriptional programs, and predicted intercellular interactions, generating hypotheses for future functional and clinical validation.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7236706741
FWCI:
Cites: 56
Cited by:
Related to: 10